Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
N-Pharma (ნ-ფარმა, n-pharma.ge) — a Tbilisi-based pharmaceutical importer and distributor (founded 2017) that sources and introduces exclusive/innovative food supplements and medicines to Georgia (e.g. Sunshine Nutrition), plus some medical devices. Import/representation, not manufacturing; active and growing through FY2024.
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|
| Total Revenue | 2,512 | 1,169 | 2,849 | 5,364 | 5,110 | 5,179 | +15.6% |
| Total COGS | 1,430 | 510 | 1,471 | 2,342 | 1,858 | 1,983 | +6.8% |
| Gross Profit | 1,082 | 659 | 1,378 | 3,022 | 3,252 | 3,196 | +24.2% |
| Gross Margin | 43.1% | 56.4% | 48.4% | 56.3% | 63.6% | 61.7% | |
| 543 | 311 | 650 | 1,010 | 1,359 | 1,786 | +26.9% | |
| EBITDA | 539 | 348 | 728 | 2,012 | 1,893 | 1,409 | +21.2% |
| EBITDA Margin | 21.4% | 29.8% | 25.6% | 37.5% | 37.0% | 27.2% | |
| Total D&A | 13 | 15 | 17 | 53 | 65 | 78 | +42.3% |
| EBIT / Operating Income | 525 | 333 | 711 | 1,960 | 1,828 | 1,331 | +20.4% |
| Total Interest Expense | 46 | 24 | 8 | 31 | 50 | 86 | +13.2% |
| Profit Before Tax | 479 | 309 | 703 | 1,929 | 1,778 | 1,245 | +21.1% |
| Total Income Tax | 0 | 1 | 18 | 93 | 160 | 163 | nmf |
| Net Profit / (Loss) | 479 | 308 | 686 | 1,836 | 1,618 | 1,082 | +17.7% |
| Net Margin | 19.1% | 26.3% | 24.1% | 34.2% | 31.7% | 20.9% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →